Prescription of Drugs to Pregnant Women in France: the HIMAGE Study
Thérapie, 58 6 (2003) 505-511
Publié en ligne : 2007-03-01
Article cité par
La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).
Article cité :
Citations de cet article :
Risk of Pregnancy Termination and Congenital Anomalies After Domperidone Exposure: A Study in the EFEMERIS Database
Mélanie Araujo, Clémentine Vabre, Justine Benevent, et al.Drug Safety 44 (7) 787 (2021)
https://doi.org/10.1007/s40264-021-01077-9
Dispensing of Potentially Harmful Prescription Drugs in 1.8 Million Pregnant Women in France: A Nationwide Study Based on Two Risk Classification Systems
Pierre-Olivier Blotière, Christine Damase-Michel, Alain Weill and Géric MauraDrug Safety 44 (12) 1323 (2021)
https://doi.org/10.1007/s40264-021-01117-4
Efficacy of phloroglucinol for the treatment of pain of gynaecologic or obstetrical origin: a systematic review of literature of randomised controlled trials
Blanchard Clara, Vanderkam Paul, Pouchain Denis, et al.European Journal of Clinical Pharmacology 76 (1) 1 (2020)
https://doi.org/10.1007/s00228-019-02745-7
Prescription médicamenteuse chez la femme enceinte au centre de santé de référence de Koutiala en 2016
A.A. Oumar, A. Guindo, M. Sanogo, Y. Cissoko, N. Magassa, S.K. Coulibaly, S. Dao and S. DoumbiaLe Pharmacien Hospitalier et Clinicien 54 (4) 325 (2019)
https://doi.org/10.1016/j.phclin.2019.08.003
The French Pregnancy Cohort: Medication use during pregnancy in the French population
Anick Bérard, Fatima Abbas-Chorfa, Behrouz Kassai, et al.PLOS ONE 14 (7) e0219095 (2019)
https://doi.org/10.1371/journal.pone.0219095
Drug use and its associated factors among pregnant women in Bahir Dar city administration, northwest Ethiopia
EW MengeshaInternational Journal of Sexual and Reproductive Health Care 2 (1) 021 (2019)
https://doi.org/10.17352/ijsrhc.000007
Recurrent Pregnancy Loss
Nisha SinghRecurrent Pregnancy Loss 305 (2018)
https://doi.org/10.1007/978-981-10-7338-0_24
Pharmacological Safety in Pregnancy: A Systematic Review On the Use of Potentially Teratogenic Drugs
Olga V. Reshetko, Konstantin A. Lutsevich and Irina I. SaninaPediatric pharmacology 14 (2) 127 (2017)
https://doi.org/10.15690/pf.v14i2.1727
Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample
Romain Demailly, Sylvie Escolano, Catherine Quantin, Pascale Tubert‐Bitter and Ismaïl AhmedPharmacoepidemiology and Drug Safety 26 (9) 1126 (2017)
https://doi.org/10.1002/pds.4265
Drug Use before and during Pregnancy in Japan: The Japan Environment and Children’s Study
Hidekazu Nishigori, Taku Obara, Toshie Nishigori, Hirohito Metoki, Mami Ishikuro, Satoshi Mizuno, Kasumi Sakurai, Nozomi Tatsuta, Ichiko Nishijima, Ikuma Fujiwara, Takahiro Arima, Kunihiko Nakai, Nariyasu Mano, Shinichi Kuriyama and Nobuo YaegashiPharmacy 5 (2) 21 (2017)
https://doi.org/10.3390/pharmacy5020021
Médicaments et grossesse : une enquête menée auprès de 374 femmes en France
Aurélie Guérin, André Rieutord, Laurie Cuche, Angela Lupattelli and Hedvig NordengTherapies 71 (6) 613 (2016)
https://doi.org/10.1016/j.therap.2016.04.005
Hépatites et grossesse
G. Ducarme, M. Schnee and V. DochezEMC - Obstétrique 39 (1) 1 (2016)
https://doi.org/10.1016/S0246-0335(15)67925-X
Hepatitis y embarazo
G. Ducarme, M. Schnee and V. DochezEMC - Ginecología-Obstetricia 52 (2) 1 (2016)
https://doi.org/10.1016/S1283-081X(16)77884-2
The Quebec Pregnancy Cohort – Prevalence of Medication Use during Gestation and Pregnancy Outcomes
Anick Bérard, Odile Sheehy and Anne CroyPLoS ONE 9 (4) e93870 (2014)
https://doi.org/10.1371/journal.pone.0093870
Évaluation des médicaments chez la femme enceinte : à propos de la base de données française EFEMERIS
Christine Damase-Michel, Isabelle Lacroix, Caroline Hurault-Delarue, Anna-Belle Beau and Jean-Louis MontastrucTherapies 69 (1) 91 (2014)
https://doi.org/10.2515/therapie/2014005
La cohorte des grossesses du Québec : prévalences et conséquences de l’utilisation des médicaments durant la grossesse
Anick Bérard and Odile SheehyTherapies 69 (1) 71 (2014)
https://doi.org/10.2515/therapie/2014011
Prevalence and Predictors of Antibiotic Administration during Pregnancy and Birth
Jakob Stokholm, Susanne Schjørring, Louise Pedersen, et al.PLoS ONE 8 (12) e82932 (2013)
https://doi.org/10.1371/journal.pone.0082932
Prenatal and perinatal analgesic exposure and autism: an ecological link
Ann Z Bauer and David KriebelEnvironmental Health 12 (1) 41 (2013)
https://doi.org/10.1186/1476-069X-12-41
Premières données épidémiologiques sur le phloroglucinol et exposition au cours du premier trimestre de grossesse
I. Lacroix, C. Hurault-Delarue, S. Kessler, et al.Gynécologie Obstétrique & Fertilité 39 (12) 694 (2011)
https://doi.org/10.1016/j.gyobfe.2011.07.013
Drug Exposure during the Periconceptional Period
Elisabeth Autret-Leca, Jean Deligne, Joffray Leve, et al.Pediatric Drugs 13 (5) 317 (2011)
https://doi.org/10.2165/11591260-000000000-00000
Prescription drug use during pregnancy in developed countries: a systematic review
Jamie R. Daw, Gillian E. Hanley, Devon L. Greyson and Steven G. MorganPharmacoepidemiology and Drug Safety 20 (9) 895 (2011)
https://doi.org/10.1002/pds.2184
Teratología y uso de medicamentos durante el embarazo
R. SerreauEMC - Ginecología-Obstetricia 47 (3) 1 (2011)
https://doi.org/10.1016/S1283-081X(11)71084-0
Tératologie et utilisation des médicaments au cours de la grossesse
R. SerreauEMC - Obstétrique 6 (2) 1 (2011)
https://doi.org/10.1016/S0246-0335(11)52462-7
Hepatitis y embarazo
G. Ducarme, J. Bernuau, C. Thuillier, P.-F. Ceccaldi and D. LutonEMC - Ginecología-Obstetricia 46 (1) 1 (2010)
https://doi.org/10.1016/S1283-081X(10)70777-3
Pharmacoepidemiological research using French reimbursement databases: yes we can!
Karin Martin‐Latry and Bernard BégaudPharmacoepidemiology and Drug Safety 19 (3) 256 (2010)
https://doi.org/10.1002/pds.1912
Vitamin, mineral and iron supplementation in pregnancy: cross-sectional study
M. Leppee, J. Culig, M. Eric, J. Boskovic and N. ColakBiopolymers and Cell 26 (2) 128 (2010)
https://doi.org/10.7124/bc.00014F
Health care providers’ requests to Teratogen Information Services on medication use during pregnancy and lactation
Marie-Pierre Gendron, Brigitte Martin, Driss Oraichi and Anick BérardEuropean Journal of Clinical Pharmacology 65 (5) 523 (2009)
https://doi.org/10.1007/s00228-008-0611-6
Hépatites et grossesse
G. Ducarme, J. Bernuau, C. Thuillier, P.-F. Ceccaldi and D. LutonEMC - Obstétrique 4 (4) 1 (2009)
https://doi.org/10.1016/S0246-0335(09)52499-4
The association of psychosocial factors with nausea and vomiting during pregnancy
Gertraud E. Markl, Christine Strunz-Lehner, Veronika Egen-Lappe, Nicholas Lack and Joerg HasfordJournal of Psychosomatic Obstetrics & Gynecology 29 (1) 17 (2008)
https://doi.org/10.1080/01674820701504528
Prescriptions et délivrances d’anti-inflammatoires non stéroïdiens après le 6e mois de grossesse : impact d’une lettre d’information envoyée par les autorités de santé
Caroline Hurault, Isabelle Lacroix, Robert Bourrel, Jean-Louis Montastruc and Christine Damase-MichelLa Presse Médicale 37 (5) 767 (2008)
https://doi.org/10.1016/j.lpm.2007.07.027
Foie et grossesse
J. BernuauEMC - Obstétrique 3 (3) 1 (2008)
https://doi.org/10.1016/S0246-0335(08)42053-7
Hígado y embarazo
J. BernuauEMC - Ginecología-Obstetricia 44 (4) 1 (2008)
https://doi.org/10.1016/S1283-081X(08)70800-2
Drug-prescribing patterns during pregnancy in the tertiary care hospitals of Pakistan: a cross sectional study
Dileep K Rohra, Nirmal Das, Syed I Azam, et al.BMC Pregnancy and Childbirth 8 (1) (2008)
https://doi.org/10.1186/1471-2393-8-24
Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance
Stephen A Ward, Esperanca JP Sevene, Ian M Hastings, François Nosten and Rose McGreadyThe Lancet Infectious Diseases 7 (2) 136 (2007)
https://doi.org/10.1016/S1473-3099(07)70025-7
Prescribing patterns of anti-emetic drugs during pregnancy in Germany
Gertraud E. Markl, Chirstine Strunz-Lehner, Veronika Egen-Lappe and Joerg HasfordArchives of Gynecology and Obstetrics 275 (6) 461 (2007)
https://doi.org/10.1007/s00404-006-0286-0
Méthodes de surveillance et de gestion des risques des médicaments pour la future mère, l’embryon, le fœtus et le nouveau-né
Evelyne Jacqz-Aigrain, Véronique Lamarque, E. Autret-Leca, et al.Therapies 61 (4) 287 (2006)
https://doi.org/10.2515/therapie:2006056
Antibiotics in pregnancy: analysis of potential risks and determinants in a large German statutory sickness fund population
Ute Amann, Veronika Egen‐Lappe, Christine Strunz‐Lehner and Joerg HasfordPharmacoepidemiology and Drug Safety 15 (5) 327 (2006)
https://doi.org/10.1002/pds.1225
Prevalence and patterns of antidepressant drug use during pregnancy
Tessa Ververs, Hans Kaasenbrood, Gerard Visser, et al.European Journal of Clinical Pharmacology 62 (10) 863 (2006)
https://doi.org/10.1007/s00228-006-0177-0
Risk Management and Monitoring Methods for the Future Mother, Embryo, Fetus, and post-natal Consequences
Evelyne Jacqz-Aigrain, Véronique Lamarque, E. Autret-Leca, et al.Therapies 61 (4) 297 (2006)
https://doi.org/10.2515/therapie:2006057
Drug prescription in pregnancy: analysis of a large statutory sickness fund population
Veronika Egen-Lappe and Joerg HasfordEuropean Journal of Clinical Pharmacology 60 (9) 659 (2004)
https://doi.org/10.1007/s00228-004-0817-1